2-Pyridinecarboxaldehyde → (1-Methyl-1H-imidazol-5-yl)(pyridin-2-yl)methanol

HRID 520841Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 520841
C([Mg]Cl)(C)C.[Cl-].[Li+].Br[C:9]1[N:13]([CH3:14])[CH:12]=[N:11][CH:10]=1.[N:15]1[CH:20]=[CH:19][CH:18]=[CH:17][C:16]=1[CH:21]=[O:22]>C1COCC1>[CH3:14][N:13]1[C:9]([CH:21]([C:16]2[CH:17]=[CH:18][CH:19]=[CH:20][N:15]=2)[OH:22])=[CH:10][N:11]=[CH:12]1

Komponenten

5

Reaktionsbedingungen

Temperatur
0 °C

Versuchsvorschrift

A solution of isopropylmagnesium chloride/lithium chloride complex (1.3 M in THF, 19.5 mL, 25.35 mmol) was added dropwise by syringe to a solution of 5-bromo-1-methyl-1H-imidazole (4.12 g, 25.58 mmol) in dry THF (130 mL) at 0° C. After 15 minutes, the Grignard solution was added via cannulation to a solution of picolinaldehyde (2.0 ml, 20.93 mmol) in dry THF (55 mL) at 0° C. The reaction mixture was stirred for 5 minutes at 0° C., then warmed to room temperature for 1 hour. The reaction mixture was then cooled in an ice bath and quenched with saturated aqueous ammonium chloride. The mixture was partitioned between brine and ethyl acetate. The separated aqueous phase was further extracted with ethyl acetate. The organic phase was dried (Na2SO4), filtered, and concentrated. The crude product was purified by flash column chromatography (silica gel, 0-5% MeOH-DCM) to provide the title compound as a white solid.

Aufarbeitung

  1. temperaturewarmed to room temperature for 1 hour
  2. temperatureThe reaction mixture was then cooled in an ice bath
  3. customquenched with saturated aqueous ammonium chloride
  4. customThe mixture was partitioned between brine and ethyl acetate
  5. extractionThe separated aqueous phase was further extracted with ethyl acetate
  6. dry with materialThe organic phase was dried (Na2SO4)
  7. filtrationfiltered
  8. concentrationconcentrated
  9. customThe crude product was purified by flash column chromatography (silica gel, 0-5% MeOH-DCM)

Quellen und Nachweise

ORD-Eintrag
ord-ce3ec1c8d3974353a11504b793e9359d
Quelldatensatz
uspto-grants-2016_05
Patentnummer
US09328095B2

Notizen zur Reaktion

Wird geladen…